Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Nirmatrelvir Emergency use authorization Experimental Antiviral Feb/15/2022 5 0
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Dec/24/2021 48 0
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
hACE21−740-Fc Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2021 1 0
scFv-IL6R-Fc Potential treatment - theoretical effect Experimental Other treatment Jun/11/2021 1 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/14/2021 6 0